- Recent Funding
- Investors
- Fred Eshelman
Fred Eshelman portfolio
Fred Eshelman has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.
About this page
It is an angel investor. Its most recent investment on record is Breakthru Medicine's $60M Series A round in February 2026, alongside Dave Morehead and Mark Gergen. That company is in Health and bio.
What Fred Eshelman invests in
- Health and bio · 1 · 100%
How Fred Eshelman invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $60M |
Fred Eshelman portfolio companies
BBreakthru Medicine$60MSeries A · Feb 2026
| Company | Round with Fred Eshelman | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $60M | $60M | Feb 5, 2026 Series A |
Most frequent co-investors
Similar investors
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Fred Eshelman. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Fred Eshelman, which is a subset of its real portfolio. API: /api/v1/investors/fred-eshelman (get a free API key). More: the most active VC firms and new venture capital funds.